Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor (QoLKAMON)
This study has been completed.
Study NCT01166477
Information provided by Sociedad Andaluza de Enfermedades Infecciosas
First Received on July 19, 2010.
Last Updated on March 19, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
